Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Hypertension Congress 2018

About Conference

Conference series LLC is proud to host CME Accredited Event 3rd International Conference on Hypertension & Healthcare during the beautiful month of August 20-21, 2018 at Tokyo, Japan the place which sees the largest influx of tourists in Tokyo. Working under the theme “ ” we bring together the brightest and most productive minds to discuss the intricate concepts of Hypertension diagnosis and management.
The conference aims to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical professionals like Directors, Heads, Deans, Professors, Scientists, Researchers, Cardiologists and Writers of the Hypertension or Cardiology and related departments, Founders and Employees of the related companies, Associations, Organizations, Laboratory members and Young researchers working in the field of hypertension treatment and management. This conference mainly focuses on spreading the awareness about challenges in this field and how to prevent and manage hypertension. 
Conference Series LLC through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. ConferenceSeries Ltd organize 600+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend?

Encounter the target market with members from across the globe, committed to learn about hypertension treatment and management. This is the best opportunity to outreach the largest gathering of participants from around the world. Conduct presentations, distribute and update knowledge about the current situation of hypertension treatment and receive name recognition at this 2-day event. World-eminent speakers, most recent researches, latest treatment techniques and the advanced updates in Hypertension Treatment and Management are the principal features of this conference.        

Target Audience:

Our Organization would be privileged to welcome the:

  • Directors of Hypertension or related Programs or Associations
  • Heads, Deans and Professors of Hypertension or Cardiology and related departments
  • Scientists and Researchers
  • Doctors
  • Writers
  • Founders and Employees of the related companies
  • Hypertension Associations and Organizations
  • Laboratory members and Students working in the field of hypertension treatment and management

Sessions And Tracks

Track 1: Hypertension

Hypertension is the condition where the blood pressure in the arteries is persistently elevated at a constant rate. This is also called as called as high blood pressure or high vital sign or blood vessel cardiovascular disease .This session principally covers the various sorts of cardiovascular disease and their assessment. There are two major categories of cardiovascular disease. The primary disease and the secondary disease. Almost 90-95 % of cases are primary and the main reason behind is the unhealthy lifestyles they follow which includes excess consumption of alcohol, salt, body weight etc. Remaining 5-10% of individuals suffer this due to narrowing of kidney arteries, chronic kidney diseases and endocrine disorder.  Assessment of cardiovascular disease primarily includes: Confirmation of hypertension, Risk factors, Underlying causes, organ injury & Indications and contraindications for medication medicine. Hypertension could be a major risk issue for cardiopathy and stroke. The American Heart Association or the AHA estimated the direct and indirect costs of hypertension in 2010 were $76.6 billion. In United States of America, almost 80% of people with hypertension are aware of their condition, 71% take some antihypertensive medication, and only 48% of people aware of it. A 2015 review of several clinical studies on how vitamin D affects blood pressure showed that restoring blood vitamin D levels by using supplements (more than 1,000 IU per day) reduced blood pressure in hypertensive individuals when they had existing vitamin D deficiency . Globally cardiovascular disease accounts for approximately 17 million deaths a year, nearly one third of the total population. Out of these, complications of hypertension account for 9.4 million deaths worldwide every year.

Relevant conferences

International Stroke Conference2018 Nursing Symposium & Pre-Con Symposia: Los Angeles Convention Center | Los Angeles, Calif on 24–26 Jan 2018;21st International Conference on Hypertension ,London, United Kingdom  on May 25-26, 2019; 20th International Conference on Hypertension May 14-15, 2018 London, United kingdom ; 20th International Conference on Hypertension, October 15-16, 2018 London, United Kingdom ; 21st International Conference on Common Cardiac Diseases and Hypertension Berlin, Germany May 21-22, 2019;21st International Conference on Clinical Cardiology, Cardiac Diseases and Hypertension Dubai, UAE May 19 - 20, 2019 ; 20th International Conference on Cardiac Diseases and Hypertension Vancouver, Canada September 17 - 18, 2018

Track 2: Hypertension and Cardiac Arrest

Cardiac arrest can be defined as a sudden stop in effective blood flow due to the failure of the heart. It  is caused when the heart's electrical system malfunctions. The individual section in the session talks about all the related heart diseases. In cardiac arrest death results when the heart suddenly stops working properly. This may be caused by abnormal, or irregular, heart rhythms, cardiomyopathy(A thickened heart muscle), Heart medications, Electrical abnormalities, Electrical abnormalities, Recreational drug uses. Some symptoms for the arrest could be sudden loss of responsiveness, abnormal breathing, fainting, fatigue, blackouts, dizziness, chest pain, shortness of breath, weakness and vomiting. The most common cause for Cardiac arrest is the coronary heart disease . Coronary artery disease often results in coronary ischemia and ventricular fibrillation. Cases have shown that the most common finding at postmortem examination of SCD is chronic high-grade stenosis of at least one segment of a major coronary artery, the arteries that supply the heart muscle with its blood supply. Left ventricular hypertrophy is thought to be the leading cause of sudden cardiac death in the adult population. Each year, more than 350,000 emergency medical services-assessed out-of-hospital cardiac arrests occur in the United State

Relevant conferences

20th International Conference on Hypertension, October 15-16, 2018 London, United Kingdom ; 21st International Conference on Common Cardiac Diseases and Hypertension Berlin, Germany May 21-22, 2019;21st International Conference on Clinical Cardiology, Cardiac Diseases and Hypertension Dubai, UAE May 19 - 20, 2019; International Stroke Conference2018 Nursing Symposium & Pre-Con Symposia: Los Angeles Convention Center | Los Angeles, Calif on 24–26 Jan 2018;21st International Conference on Hypertension ,London, United Kingdom  on May 25-26, 2019

Track 3: Hypertension and Obesity

Hypertension refers to the pressure that blood applies to the inner walls of the arteries. Obesity increases the chances of cardiovascular disease. The individual session in this focuses on obesity-related cardiovascular disease, its interaction with the outcomes of hypertension, risk factors, treatment and management of cardiovascular disease. Obesity-associated arterial hypertension is characterized by activation of the sympathetic system, activation of the renin-angiotensin system, and sodium retention, among different abnormalities. It's calculable that excess weight, accounted for about twenty sixth of cases of cardiovascular disease in men and twenty eighth in ladies, and for about twenty third of cases of coronary cardiovascular disease in men and 15 % in ladies. Obese people have a rise in adipose tissue that will increase their tube resistance and successively will increase the work the heart must do to pump blood throughout the body. Anti-hypertension medications ought to be started if hypertension is diagnosed. But, with weight-loss, a major fall in force per unit area could allow a decrease within the range of medicines taken or decrease the quantity of medication taken. Prevention would be better than any drug.

Relevant conferences

 21st International Conference on Common Cardiac Diseases and Hypertension Berlin, Germany May 21-22, 2019;21st International Conference on Clinical Cardiology, Cardiac Diseases and Hypertension Dubai, UAE May 19 - 20, 2019 ; 20th International Conference on Cardiac Diseases and Hypertension Vancouver, Canada September 17 - 18, 2018; International Stroke Conference2018 Nursing Symposium & Pre-Con Symposia: Los Angeles Convention Center | Los Angeles, Calif on 24–26 Jan 2018;21st International Conference on Hypertension, London, United Kingdom  on May 25-26, 2019; 20th International Conference on Hypertension May 14-15, 2018 London, United kingdom ; 20th International Conference on Hypertension, October 15-16, 2018 London, United Kingdom ;

Track 4: Resistance Hypertension

Resistant hypertension is defined as blood pressure that remains above goal in spite of the concurrent use of 3 antihypertensive agents of different classes. This section talks about the Resistance Hypertension causes, diagnostics, treatments and controls ideally, one of the 3 agents should be a diuretic and all agents should be prescribed at optimal dose amounts. Although arbitrary in regard to the number of medications required, resistant hypertension is thus defined in order to identify patients who are at high risk of having reversible causes of hypertension and/or patients who, because of persistently high blood pressure levels, may benefit from special diagnostic and therapeutic considerations. As defined, resistant hypertension includes patients whose blood pressure is controlled with use of more than 3 medications. That is, patients whose blood pressure is controlled but require 4 or more medications to do so should be considered resistant to treatment.

Relevant conferences

20th International Conference on Hypertension, October 15-16, 2018 London, United Kingdom ; 21st International Conference on Common Cardiac Diseases and Hypertension Berlin, Germany May 21-22, 2019;21st International Conference on Clinical Cardiology, Cardiac Diseases and HypertensionDubai, UAE May 19 - 20, 2019; International Stroke Conference2018 Nursing Symposium & Pre-Con Symposia: Los Angeles Convention Center | Los Angeles, Calif on 24–26 Jan 2018;21st International Conference on Hypertension,London, United Kingdom  on May 25-26, 2019

Track 5: Renal Hypertension

Renal hypertension also called as Reno vascular high blood pressure, is elevated pressure caused by nephrosis. It's a syndrome that consists of high pressure caused by the kidneys' secretion response to narrowing of the arteries activity the kidneys (renal artery stenosis). Once functioning properly this secretion axis regulates pressure. Due to low native blood flow, the kidneys erroneously increase pressure of the complete vascular system. It's a kind of secondary high blood pressure, a kind of hypertension whose cause is classifiable. This session mainly accounts for the assorted causes and symptoms of reno vascular high blood pressure, along side of its pathological process, diagnosis and treatment. High pressure is dangerous partially as a result of the patients usually don't expertise the symptoms, thus organ injury will occur slowly while not being recognized. Varied techniques are developed to diagnose excretory organ high blood pressure victimization digital image process of radiographs. Medications are used initial to manage high pressure in excretory organ high blood pressure. In some individuals with renal high blood pressure due to narrowing of the arteries, even taking 3 or a lot of medications each day might not adequately manage pressure. In these situations, a procedure like angioplasty or stenting, to improve blood flow to the kidneys can often help.

Relevant conferences

International Stroke Conference2018 Nursing Symposium & Pre-Con Symposia: Los Angeles Convention Center | Los Angeles, Calif on 24–26 Jan 2018;21st International Conference on Hypertension,London, United Kingdom  on May 25-26, 2019; 20th International Conference on Hypertension May 14-15, 2018 London, United kingdom ; 20th International Conference on Hypertension, October 15-16, 2018 London, United Kingdom ; 21st International Conference on Common Cardiac Diseases and Hypertension Berlin, Germany May 21-22, 2019;21st International Conference on Clinical Cardiology, Cardiac Diseases and Hypertension Dubai, UAE May 19 - 20, 2019 ; 20th International Conference on Cardiac Diseases and Hypertension Vancouver, Canada September 17 - 18, 2018

Track 6: Pulmonary Hypertension

Pulmonary hypertension or PH is high blood pressure that affects the arteries in lungs and the right side of heart. In one form of pulmonary hypertension, tiny arteries in lungs and capillaries become narrowed, blocked or destroyed. This makes it harder for blood to flow through the lungs and thus raises pressure within lung walls. As the pressure builds, the heart's lower right chamber works harder to pump blood through lungs, eventually causing the heart muscle to fail. Some forms of pulmonary hypertension are serious conditions that become progressively worse and are sometimes fatal. This session mainly talks about the classification, signs, symptoms and treatments of the Pulmonary Hypertension.

Relevant conferences

 21st International Conference on Common Cardiac Diseases and Hypertension Berlin, Germany May 21-22, 2019;21st International Conference on Clinical Cardiology, Cardiac Diseases and HypertensionDubai, UAE May 19 - 20, 2019 ; 20th International Conference on Cardiac Diseases and Hypertension Vancouver, Canada September 17 - 18, 2018; International Stroke Conference2018 Nursing Symposium & Pre-Con Symposia: Los Angeles Convention Center | Los Angeles, Calif on 24–26 Jan 2018;21st International Conference on Hypertension, London, United Kingdom  on May 25-26, 2019; 20th International Conference on Hypertension May 14-15, 2018 London, United kingdom ; 20th International Conference on Hypertension, October 15-16, 2018 London, United Kingdom.

 

Track 7: Gestational Hypertension

Gestational hypertension or pregnancy-induced hypertension (PIH) is that the development of recent cardiovascular disease in a every pregnant lady when twenty weeks gestation while not the presence of super molecule within the excretory product or different signs of Pre-eclampsia. It's a brief identification for hypertensive pregnant ladies who don't meet criteria for pre-eclampsia or chronic cardiovascular disease. The identification is modified to, pre-eclampsia, if symptom or new signs of end-organ pathology develop and chronic (primary or secondary) cardiovascular disease, if blood pressure elevation persists ≥12 weeks postnatal. The risk factors for Gestational hypertension comprise maternal causes like obesity, past history or adolescent maternity, multiple gestations, and case history. There's no specific treatment, however it's monitored closely to quickly establish pre-eclampsia and its grave complications. Drug treatment choices are restricted, as several medications might negatively have an effect on the craniate. Throughout Gestational hypertension ladies should be offered an integrated package of care, covering admission to hospital, treatment, activity of blood pressure, testing for symptom and blood tests. There is no specific treatment for the disease but the pre-eclampsia is monitored closely. The dosage of the same is also kept to minimum or to limited.

Relevant conferences

21st International Conference on Hypertension, London, United Kingdom  on May 25-26, 2019; 20th International Conference on Hypertension May 14-15, 2018 London, United kingdom ;  21st International Conference on Common Cardiac Diseases and Hypertension Berlin, Germany May 21-22, 2019;21st International Conference on Clinical Cardiology, Cardiac Diseases and Hypertension Dubai, UAE May 19 - 20, 2019 ; 20th International Conference on Cardiac Diseases and Hypertension Vancouver, Canada September 17 - 18, 2018; International Stroke Conference2018 Nursing Symposium & Pre-Con Symposia: Los Angeles Convention Center | Los Angeles, Calif on 24–26 Jan 2018

Track 8: Hypertension – Stress and Stroke

Stressful situations can lead the blood to spike up temporarily but sometimes it may cause high blood pressure too. Research is still in progress to find out about it. According to some reports the change in the blood pressure behavior can be due to various habits like overeating, drinking or poor sleeping. It’s possible that health conditions related to stress like anxiety, depression and isolation from friends and family may lead to a heart disease but not to a high blood pressure condition. Some hormonal changes may damage your arteries leading towards heart disease. According to National Health Interview Survey, almost 75% of the general population experiences some stress every week.  A stroke occurs when a blood vessel to the brain is either blocked by a clot or bursts, a part of the brain stops to get the required amount of blood and oxygen and hence it starts to die . Since the brain controls the entire body so it can threaten one’s ability to think, move and function. Hence Hypertension is the most prevalent and powerful modifiable risk factor for stroke. Persons with hypertension are about 3 or 4 times more likely to have a stroke. Hypertension remains the single most important modifiable risk factor for stroke, and the impact of hypertension and nine other risk factors together account for 90% of all strokes. The two major types of stroke include ischemic stroke (caused by blood clots), which accounts for 85% of strokes, and hemorrhagic stroke (bleeding in the brain), which accounts for 15% of strokes. Prevention of stroke is a major public health priority, but needs to be based on a clear understanding of the key preventable causes of stroke.

Relevant conferences

21st International Stroke Conference2018 Nursing Symposium & Pre-Con Symposia: Los Angeles Convention Center | Los Angeles, Calif on 24–26 Jan 2018;21st International Conference on Hypertension,London, United Kingdom  on May 25-26, 2019; 20th International Conference on Hypertension May 14-15, 2018 London, United kingdom ; 20th International Conference on Hypertension, October 15-16, 2018 London, United Kingdom ; 21st International Conference on Common Cardiac Diseases and Hypertension Berlin, Germany May 21-22, 2019;21st International Conference on Clinical Cardiology, Cardiac Diseases and Hypertension Dubai, UAE May 19 - 20, 2019;

Track 9: Causative Factors and Risk Assessment

High blood pressure has several causative factors like age, race, case history and obesity, not being physically active, overwhelming tobacco, an excessive amount of salt (sodium) in diet, deficient VitaminD in diet, drinking an excessive amount of alcohol, stress and bound chronic conditions. Though high pressure is commonest in adults, youngsters are also in danger, too. For a few youngsters, high pressure is caused by issues with the kidneys or heart except for a growing variety of youngsters, poor fashion habits, like an unhealthy diet, fleshiness, physiological condition and lack of exercise contributes to high pressure. Certain diseases and medications are specific causes of high pressureCardiovascular disease represents the leading reason for morbidity and mortality in Western countries, and hypertension-related vessel events have an effect on regarding 37 million individuals annually, worldwide. During this perspective, hypertensive patients are at hyperbolic risk to expertise vessel events throughout life-long period, and treatment of high pressure represents one among the foremost effective ways to cut back cardiovascular risk.

Relevant conferences

20th International Conference on Hypertension May 14-15, 2018 London, United kingdom ;  21st International Conference on Common Cardiac Diseases and Hypertension Berlin, Germany May 21-22, 2019; 21st International Stroke Conference2018 Nursing Symposium & Pre-Con Symposia: Los Angeles Convention Center | Los Angeles, Calif on 24–26 Jan 2018 21st International Conference on Clinical Cardiology, Cardiac Diseases and Hypertension Dubai, UAE May 19 - 20, 2019 ; 20th International Conference on Cardiac Diseases and Hypertension Vancouver, Canada September 17 - 18, 2018

Track 10: Diet and Exercise for Hypertension

High blood pressure, which is also called hypertension, increases the risk of developing many serious health problems, including heart disease, stroke, and kidney disease. Evaluation and Treatment of High Blood Pressure recommendations have defined “hypertension” as a BP of ≥140/90 mm Hg. The risk of cardiovascular disease in the patient with hypertension can be greatly reduced with effective antihypertensive therapy. Maintaining normal body weight, following a proper diet plan, exercising regularly, avoiding high-sodium content foods, limited alcohol consumption and appropriate medications as prescribed by the doctor may lead to a controlled and manageable blood pressure account. Also monitoring the blood pressure regularly may prevent hypertension and reduce the risk of high blood pressure-related health problems.

Relevant conferences

20th International Conference on Heart Diseases and Hypertension Toronto, Canada June 21 - 22, 2018. International Stroke Conference2018 Nursing Symposium & Pre-Con Symposia: Los Angeles Convention Center | Los Angeles, Calif on 24–26 Jan 2018;21st International Conference on Hypertension, London, United Kingdom  on May 25-26, 2019; 20th International Conference on Hypertension May 14-15, 2018 London, United kingdom ; 20th International Conference on Hypertension, October 15-16, 2018 London, United Kingdom ; 21st International Conference on Common Cardiac Diseases and Hypertension Berlin, Germany May 21-22, 2019

Track 11: Hypertension Treatments

 High blood pressure can be cured. The disease can be controlled by following a proper and healthy lifestyle. As per recommended by various doctors by having a healthy lifestyle, eating less salt in your regular diet, quitting smoking, consuming limited amount of alcohol can help in curing the disease. In addition to this regular exercise will also help in controlling the disease. Drug treatments are available too for Hypertension. Various drugs are available in market that allow the individual person to do that in which few are--  Thiazide diuretics, Beta blockers, Angiotensin II receptor blockers (ARBs), Calcium channel blockers, Central-acting agents, Alpha blockers, Aldosterone antagonists.

Relevant conferences

20th International Conference on Hypertension, October 15-16, 2018 London, United Kingdom ; 21st International Conference on Common Cardiac Diseases and Hypertension Berlin, Germany May 21-22, 2019 20th International Conference on Heart Diseases and Hypertension Toronto, Canada June 21 - 22, 2018. International Stroke Conference2018 Nursing Symposium & Pre-Con Symposia: Los Angeles Convention Center | Los Angeles, Calif on 24–26 Jan 2018;21st International Conference on Hypertension, London, United Kingdom  on May 25-26, 2019; 20th International Conference on Hypertension May 14-15, 2018 London, United kingdom ; 20th International Conference on Hypertension, October 15-16, 2018 London, United Kingdom ;

Track 12: Advanced Treatments Approaches

Treating high blood pressure can take a multi-pronged approach including diet changes, medication, and exercise. Hypertension, or high blood pressure, is dangerous because it can lead to strokes, heart attacks, heart failure, or kidney disease. The goal of hypertension treatment is to lower high blood pressure and protect important organs, like the brain, heart, and kidneys from damage. Treatment for hypertension has been associated with reductions in stroke (reduced an average of 35%-40%), heart attack (20%-25%), and heart failure (more than 50%), according to research.Because hypertension rarely causes specific symptoms, it is not identified until an individual’s blood pressure is measured by a physician or it causes a catastrophic complication such as stroke or heart attack. Accurate diagnosis by blood pressure measurement is essential. Many advanced treatment approaches and medications have been established for the treatment and management of hypertension that may describe this session.

Relevant conferences

21st International Conference on Hypertension, London, United Kingdom  on May 25-26, 2019; 20th International Conference on Hypertension May 14-15, 2018 London, United kingdom ; 20th International Conference on Hypertension, October 15-16, 2018 London, United Kingdom ; 20th International Conference on Hypertension, October 15-16, 2018 London, United Kingdom ; 21st International Conference on Common Cardiac Diseases and Hypertension Berlin, Germany May 21-22, 2019 20th International Conference on Heart Diseases and Hypertension Toronto, Canada June 21 - 22, 2018. International Stroke Conference2018 Nursing Symposium & Pre-Con Symposia: Los Angeles Convention Center | Los Angeles, Calif on 24–26 Jan 2018;

Track 13: Clinical Case Reports

High blood pressure, also known as hypertension, affects millions -- even children and teens. It is a common condition that catches up with most people who live into older age. The exact cause of hypertension is unknown, but there are several factors and conditions that may contribute to its occurrence. In USA about 82% of the total population is suffering from Hypertension.

Relevant conferences

20th International Conference on Hypertension May 14-15, 2018 London, United kingdom ;  21st International Conference on Common Cardiac Diseases and Hypertension Berlin, Germany May 21-22, 2019; 21st International Stroke Conference2018 Nursing Symposium & Pre-Con Symposia: Los Angeles Convention Center | Los Angeles, Calif on 24–26 Jan 2018 21st International Conference on Clinical Cardiology, Cardiac Diseases and Hypertension Dubai, UAE May 19 - 20, 2019 ; 20th International Conference on Cardiac Diseases and Hypertension Vancouver, Canada September 17 - 18, 2018

Few reports are given below:

      

Age-adjusted awareness, treatment, and control of hypertension among adults with hypertension: United States, 2009–2012

     

Global Report on Hypertension

             

Projected Mortality Trend from 2008 to 2030 for Major Communicable and Non-Communicable Diseases

Track 14: Hypertension and Diabetes.

Hypertension can lead to many complications of Diabetes. Most people affected with Diabetes are more prone to suffer Hypertension. Diabetes damages the arteries and make them targets for hardening (also called as atherosclerosis) and if it is not treated then it may also cause blood vessel damage, heart attack, and kidney failure too. In this section of the main we discuss about various types of Diabetes , risk factors that are involved into it, controlling hypertension in patients with Diabetes and Treatment.

Relevant conferences

20th International Conference on Hypertension, October 15-16, 2018 London, United Kingdom ; 21st International Conference on Common Cardiac Diseases and Hypertension Berlin, Germany May 21-22, 2019 20th International Conference on Heart Diseases and Hypertension Toronto, Canada June 21 - 22, 2018. International Stroke Conference2018 Nursing Symposium & Pre-Con Symposia: Los Angeles Convention Center | Los Angeles, Calif on 24–26 Jan 2018;21st International Conference on Hypertension, London, United Kingdom  on May 25-26, 2019; 20th International Conference on Hypertension May 14-15, 2018 London, United kingdom ; 20th International Conference on Hypertension, October 15-16, 2018 London, United Kingdom.

Market Analysis

ConferenceSeries Ltd is glad to invite you to the CME Accredited Event “3rd International Conference on Hypertension & Healthcare” to be held during August 20-21, 2018 at Tokyo, Japan. The conference emphasizes the theme “ ” focusing on the latest ideas and advances for hypertension treatment and management. Hypertension 2018 event welcomes the innovative strategies in the area of hypertension research and also proposes a unique opportunity for the explorers from all over the world to gather, share and perceive new scientific interactions upon the various perceptions of hypertension.

ConferenceSeries Ltd organizes 600+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

For more details please visit: http://hypertensioncongress.conferenceseries.com/

 

Conference Highlights 

  • Hypertension
  • Hypertension and Cardiac Arrest
  • Hypertension and Obesity
  • Resistance Hypertension
  • Renal Hypertension
  • Pulmonary Hypertension
  • Gestational Hypertension
  • Hypertension - Stress and Stroke
  • Causative Factors and Risk Assessment 
  • Diet and Exercise For Hypertension
  • Hypertension Treatments
  • Advanced Treatments Approaches
  • Clinical Case Reports

Importance and Scope:

Hypertension is a major risk factor for cardiovascular diseases, cerebrovascular events and ischaemic heart diseases, so is therefore one of the most important preventable causes of premature morbidity and mortality in developed and developing countries. It is often symptomless, so screening is vital before damage is done. Many surveys continue to show that hypertension remains underdiagnosed, undertreated and poorly controlled. Overall, the prevalence of hypertension (at least ≥140/90 mm Hg or on treatment) in those aged over 35 was observed to be 32% in men and 27% in women.

Hypertension 2018 is an international platform for presenting research about Hypertension and related concepts, sharing alternative ideas about the severe cardiovascular risk factor, contributing to the dissemination of information about the trouble for the welfare of the society.

Why Japan?

Japan’s ability to conduct independent research is a decisive factor in boosting nation’s competitiveness. A place for conducting good research for hypertension and cardiovascular research with having institutes like Advanced Medical Research Centers, National Institutes for Basic Biology and many more centers will come in handy. The important research conducted in Japan is Clinical Research which includes pre-clinical and Clinical Trials. With 5% of GNP , Japan is unique in their science and the availability of raw materials to industrial companies offers them excellent research opportunities.

 

Societies Associated with Hypertension

  • Arun dal heart associates
  • Cardiology Associates, LLC Annapolis
  • Cardiology Associates, LLC Kent Island
  • Cardiovascular Specialists of Frederick
  • Chesapeake and Washington Heart Care, PC
  • Chesapeake Cardiovascular Associates- Woodholme
  • Child Cardiology Associates
  • Delaware Cardiovascular Associates Elkton Office
  • Patuxent Cardiology Associates
  • Steward Medical Group, LLC
  • Steward Physician Network, Inc.
  • Suburban Cardiology and Internal Medicine, PC
  • The Cardiovascular Specialists.

Hospitals Associated with Hypertension

  • American Cardiology and Nuclear Practice
  • AMG Cardiovascular Consultants
  • BehringHospital Vall D'Hebron, Laboratorio ecocardiografia, Barcelona
  • Calvert Cardiology Clinic
  • Cardio Care, LLC
  • Cardiology and Internal Medicine PA
  • Cardiology Center
  • Cardiovascular Center Of Hagerstown
  • Cardiovascular Diagnostic Center, PA
  • Columbia Cardiac Care
  • Coronary Artery Disease NSC "The M. D. Strazhesko Institute of Cardiology" Kiev
  • Delmarva Heart, LLC
  • Doctors Community Hospital
  • Suburban Cardiology and Internal Medicine, PC
  • Taunton Satellite Office
  • The Cambridge Hospital
  • The Heart Center of Metro West
  • The Plymouth Heart Center
  • Tufts Medical Center
  • UMass Memorial Health Care Cardiac Ultrasound Laboratory
  • UMass Memorial Medical Health Care-Memorial Campus
  • West Roxbury Veterans Affairs Medical Center
  • Whidden Hospital
  • Winchester Cardiac Ultrasound
  • Winchester Hospital Echocardiography Laboratory
  • WPA-Woburn Medical

Past Conferences

Hypertension 2016

We would like to thank all of our wonderful speakers, conference attendees, students, associations and guests for making Hypertension 2016 a wonderful event!

Thank you for participating in the International Conference on Hypertension & Healthcare (Hypertension-2016).

It was a great pleasure seeing many familiar faces, several new ones, and many others who have just joined the Hypertension-2016 at the Holiday Inn Toronto International Airport, Canada.

We hope you had a remarkable time at the conference.

Thank you to all the Honorable Guests, Keynote Speakers, Moderator, Chairs, Co-Chairs, Speakers, Students and Delegates, the Organizing Committee and Editorial Board members for their support. The conference would not have been the same without each one of you.
We enjoyed hosting the event and hope you walked away with new ideas, inspiration and ambition to promote work in all possible ways.

Conference series LLC played host to a diverse panel of key members of the Hypertension community from research lab, industry, academia and financial investment practices, discussing the future of Hypertension specialties. This event was really aimed for examining where the real Hypertension specialties are going in the future and purpose of the event was to provide an opportunity for cross fertilization of ideas and development of ideas, in the field of Hypertension.

Focusing on Hypertension & ObesityHypertension Risk factorsHypertension DiagnosisGestational HypertensionHypertension ManagementCase Reports & Hypertension Epidemiology as well, the two days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

The highlights of the meeting were the eponymous lectures, delivered by Pavel Hamet from University of Montreal, Canada , Naranjan S Dhalla, University of Manitoba, Canada , Pollen K F Yeung , Dalhousie University, Canada, Robert S Fitzgerald, Johns Hopkins University, USA, These talks were of great interest to the general cardiologists and were enormously informative.

Conference series LLC International Conference on Hypertension & Healthcare was a great success with the support of international, multi professional steering committee and coordinated by the Journal of Clinical & Experimental Cardiology, Journal of Hypertension: Open Access , Journal of Cardiovascular Diseases & Diagnosis and Cardiovascular Pharmacology: Open Access.

Past Conference Report

Hypertension 2017

Past Reports  Proceedings  Gallery  

Hypertension 2016

Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date August 20-21 , 2018

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Supported By

Journal of Hypertension Journal of Cardiovascular Diseases & Diagnosis Journal of Clinical & Experimental Cardiology

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Past Affiliations

Speaker Logos

Keytopics

  • Ambulatory Blood Pressure
  • Antihypertensive Drugs
  • Antihypertensive Pharmacology
  • Antihypertensive Therapy
  • Arterial Hypertension
  • Atherosclerosis
  • Blood Pressure
  • Blood Pressure Control
  • Cardiac Arrest
  • Cardiologists Education
  • Cardiology
  • Cardiovascular Diseases
  • Cardiovascular Surgery
  • Causes Of Hypertension
  • Clinical Case Reports
  • Drug-induced Hypertension
  • Endocrine Hypertension
  • Experimental Hypertension
  • Gestational Hypertension
  • Heart Failure
  • High Blood Pressure
  • Hyperkinetic Borderline Hypertension
  • Hypertension
  • Hypertension Awareness
  • Hypertension Care Strategies
  • Hypertension Diagnosis
  • Hypertension Diet
  • Hypertension Differential Diagnosis
  • Hypertension Epidemiology
  • Hypertension In Infancy
  • Hypertension Incidence
  • Hypertension Management
  • Hypertension Nursing Care
  • Hypertension Prevalence
  • Hypertension Prevention
  • Hypertension Risk Factor
  • Hypertension Symptoms
  • Hypertension Treatment
  • Hypertensive Crisis
  • Hypertensive Disorders
  • Hypertensive Emergency
  • Hypertensive Encephalopathy
  • Hypertensive Heart Disease
  • Hypertensive Nephropathy
  • Hypertensive Renal Damage
  • Hypertensive Retinopathy
  • Hypertensive Vascular Disease
  • Hyperuricemia & Metabolic Syndrome
  • Hypoxic Pulmonary Hypertension
  • Idiopathic Intracranial Hypertension
  • Immunological Basis Of Hypertension
  • Nattokinase Effects
  • Naturopathic Remedies
  • Nursing Management Of Hypertension
  • Obesity & Hypertension
  • Ocular Hypertension
  • Outward Symptoms Of Hypertension
  • Pathophysiology Of Hypertension
  • Pediatric Cardiologists
  • Pediatric Hypertension
  • Perioperative Management Of Hypertension
  • Portal Hypertension
  • Post Exercise Hypotension
  • Primary Hypertension
  • Pulmonary Hypertension
  • Renal Hypertension
  • Resistant Hypertension
  • Sphygmomanometer
  • Thiazide Diuretics
  • Vitamin D And Hypertension